97927-95-2 Usage
Uses
Used in Medicinal Chemistry:
Ethanone, 1-[2-(methylamino)phenyl]-2-(1-methyl-1H-tetrazol-5-yl)-, is used as a chemical intermediate for the synthesis of various pharmaceutical compounds due to its unique structure and potential biological activity. The presence of the methylamino and tetrazol-5-yl groups may confer specific molecular properties that could be beneficial for drug development.
Used in Pharmaceutical Research:
In the pharmaceutical industry, Ethanone, 1-[2-(methylamino)phenyl]-2-(1-methyl-1H-tetrazol-5-yl)-, is utilized for exploring its potential as a lead compound in the development of new drugs. Its unique molecular structure may offer advantages in targeting specific biological pathways or receptors, contributing to the discovery of novel therapeutic agents.
Further research is likely needed to fully understand the properties and potential uses of this chemical compound, including its stability, solubility, and interactions with biological systems. This knowledge will be crucial in optimizing its application in medicinal chemistry and pharmaceutical research.
Check Digit Verification of cas no
The CAS Registry Mumber 97927-95-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,7,9,2 and 7 respectively; the second part has 2 digits, 9 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 97927-95:
(7*9)+(6*7)+(5*9)+(4*2)+(3*7)+(2*9)+(1*5)=202
202 % 10 = 2
So 97927-95-2 is a valid CAS Registry Number.
97927-95-2Relevant academic research and scientific papers
Antihypertensive 3-tetrazoyl-4-quinolones
-
, (2008/06/13)
Novel quinolones of formula I STR1 and pharmaceutically acceptable acid addition salts thereof in which the dotted line between positions 2 and 3 of the quinolone ring represents an optional bond, R is hydrogen, 1-methyl or 2-lower alkyl; R1 is lower alkyl; R2 is hydrogen, halo, lower alkyl, lower alkoxy, trifluoromethyl, cyano, difluoromethoxy, methylsulphinyl, phenylsulphinyl or the group --NR4 R5 or the N-oxide thereof wherein R4 and R5, which may be the same or different, are lower alkyl or, together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino or morpholino radical; and R3 is hydrogen, fluoro, lower alkyl or lower alkoxy provided that, when R3 is lower alkoxy, R2 is other than lower alkoxy have utility as antihypertensive agents. Processes for preparing the quinolones and pharmaceutical compositions containing them are disclosed.
